News Announcement

Claris Lifesciences: Exit Letter Of Offer

Exit Letter of Offer to the remaining public shareholders (Residual Public Shareholders) of Claris Lifesciences Limited (Company) for the acquisition of 22,88,697 (Twenty Two Lakh Eighty Eight Thousand Six Hundred and Ninety Seven) fully paid up Equity Shares (representing 4.19% of the paid up share capital of the Company) held by the Residual Public Shareholders of the Company, pursuant to Regulation 21 of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, as amended from time to time (the Delisting Regulations).

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan